<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01145911</url>
  </required_header>
  <id_info>
    <org_study_id>IGPS</org_study_id>
    <nct_id>NCT01145911</nct_id>
  </id_info>
  <brief_title>The Study of Ocular Hemodynamics With Glaucoma Progression</brief_title>
  <acronym>IGPS</acronym>
  <official_title>The Study of Ocular Hemodynamics With Glaucoma Progression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the relationships between ocular hemodynamics and glaucomatous optic neuropathy
      progression.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. To determine whether baseline ocular blood flow values are predictive of glaucomatous
           progression as determined by visual field analysis.

        2. To determine how changes in ocular blood flow are related to visual field progression.

        3. To determine how changes in ocular blood flow are related to changes in optic nerve
           structure and topographic change over time.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">July 3, 2014</completion_date>
  <primary_completion_date type="Actual">July 3, 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ocular Blood Flow</measure>
    <time_frame>various</time_frame>
    <description>per visit</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">123</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Glaucoma patients</arm_group_label>
    <description>Glaucoma patients</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Glaucoma patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients will meet all of the following inclusion criteria to enter the study:

          1. Age: 30 years or older.

          2. Diagnosis: confirmed open-angle glaucoma in at least one eye:

               1. glaucomatous visual field loss on Humphrey 24-2 or 10-2 perimetry

               2. glaucomatous optic disc cupping

               3. agreement between two baseline exams for reliability

          3. Best corrected visual acuity at least 20/60 in at least one eye.

          4. Prior Humphrey visual fields demonstrate acceptable reliability standards (see below).

        Exclusion Criteria:

          1. Extensive Humphrey visual field damage consisting of either a mean deviation (MD) &lt;
             -15 decibels or a clinically determined threat to fixation in both hemifields.

          2. Evidence of exfoliation or pigment dispersion.

          3. History of acute angle-closure or a narrow, occludable anterior chamber angle by
             gonioscopy.

          4. History of chronic or recurrent inflammatory eye diseases (e.g., scleritis, uveitis).

          5. History or signs of intraocular trauma.

          6. Severe or potentially progressive retinal disease such as retinal degeneration,
             diabetic retinopathy, and retinal detachment.

          7. Any abnormality preventing reliable applanation tonometry.

          8. Current use of any ophthalmic or systemic steroid which may interfere with this
             investigation.

          9. Cataract surgery within the past year.

         10. Resting pulse &lt; 50 beats per minute.

         11. Severe, unstable or uncontrolled cardiovascular, renal, or pulmonary disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alon Harris, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Indiana University School of Medicine, Department of Ophthalmology</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 15, 2010</study_first_submitted>
  <study_first_submitted_qc>June 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2010</study_first_posted>
  <last_update_submitted>March 6, 2017</last_update_submitted>
  <last_update_submitted_qc>March 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glaucoma</keyword>
  <keyword>Blood Flow</keyword>
  <keyword>Progression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Disease Progression</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

